Clinical trial
Dendritic Cell Vaccination in Patients With Advanced Colorectal Cancer
NCT00311272 · University Hospital, Gentofte, Copenhagen, Other · Completed
Key facts
| NCT number | NCT00311272 |
|---|---|
| Title | Dendritic Cell Vaccination in Patients With Advanced Colorectal Cancer |
| Official title | Vaccination With Autologous Dendritic Cells Pulsed With Allogenous Melanoma Lysate (MelCancerVac) for Treatment of Patients With Advanced Colorectal Cancer |
| Lead sponsor | University Hospital, Gentofte, Copenhagen, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Neoplasms |
| Intervention type | Biological |
| Interventions | MelCancerVac |
| Enrollment | 40 |
| Start date | Nov 1, 2004 |
| Completion | Sep 1, 2007 |
| First posted | Apr 5, 2006 |
| Last update posted | Feb 18, 2009 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: